Prolight Diagnostics AB (LTS:0G5I) YoY EBITDA Growth : 101.04% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Prolight Diagnostics AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Prolight Diagnostics AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 101.04%.

Prolight Diagnostics AB's EBITDA per Share for the three months ended in Dec. 2024 was kr0.00.

Prolight Diagnostics AB YoY EBITDA Growth Historical Data

The historical data trend for Prolight Diagnostics AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB YoY EBITDA Growth Chart

Prolight Diagnostics AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

15.15

-64.29

100.00

92.17

Prolight Diagnostics AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															-	30.77	34.48	55.88	101.04

Prolight Diagnostics AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Prolight Diagnostics AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.043	-	-0.549)	/	\| -0.549 \|
=	92.17 %

Prolight Diagnostics AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.004	-	-0.386)	/	\| -0.386 \|
=	101.04 %

Prolight Diagnostics AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Prolight Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (LTS:0G5I) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PRLD:Sweden

Address

Gasverksgatan 3A, Lund, SWE, 222 29

Website

https://www.prolightdx.com

Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.

Prolight Diagnostics AB Headlines

No Headlines